These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36941812)

  • 21. Limited role for ivabradine in the treatment of chronic heart failure.
    Cullington D; Goode KM; Cleland JG; Clark AL
    Heart; 2011 Dec; 97(23):1961-6. PubMed ID: 21917660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Heart rate control in chronic heart failure patients received cardiovascular implantable electronic device therapy: effects of optimized medication].
    Gao Y; Liang YC; Yu HB; Yan XL; Xu BG; Liu R; Wang N; Xu GQ; Wang ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):173-177. PubMed ID: 29562420
    [No Abstract]   [Full Text] [Related]  

  • 23. Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    Ye F; Wang X; Wu S; Ma S; Zhang Y; Liu G; Liu K; Yang Z; Pang X; Xue L; Lu S; Zhong M; Li J; Yu H; Lou D; Cui D; Xie X; Wang J;
    J Am Coll Cardiol; 2022 Aug; 80(6):584-594. PubMed ID: 35926931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological therapy of heart failure with reduced ejection fraction].
    Wieser M; Rhyner D; Martinelli M; Suter T; Schnegg B; Bösch C; Wigger O; Dobner S; Hunziker L
    Ther Umsch; 2018 Sep; 75(3):180-186. PubMed ID: 30145973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of Ivabradine Therapy in Up-Titrating Beta-Blocker Dose in Patients with Systolic Dysfunction.
    Imamura T; Onoda H; Uchida K; Kinugawa K
    Int Heart J; 2021 Nov; 62(6):1305-1309. PubMed ID: 34744149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U; Stöckl G; Werdan K
    Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction.
    Cammarano C; Silva M; Comee M; Donovan JL; Malloy MJ
    Clin Ther; 2016 Feb; 38(2):387-95. PubMed ID: 26839043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable coronary artery disease: are there therapeutic benefits of heart rate lowering?
    Tanna MS; Messerli FH; Bangalore S
    J Hypertens; 2019 Jun; 37(6):1112-1118. PubMed ID: 30676481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Fox K; Ford I; Steg PG; Tendera M; Ferrari R;
    Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart rate reduction in heart failure: ivabradine or beta blockers?
    Guglin M
    Heart Fail Rev; 2013 Jul; 18(4):517-28. PubMed ID: 22972475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.
    Bryan Richard S; Huang B; Liu G; Yang Y; Luo S
    Clin Cardiol; 2021 Apr; 44(4):463-471. PubMed ID: 33638556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice.
    Zugck C; Martinka P; Stöckl G
    Adv Ther; 2014 Sep; 31(9):961-74. PubMed ID: 25160945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ivabradine and metoprolol in fixed dose combination: When, why and how to use it.
    Katsi V; Skalis G; Kallistratos MS; Tsioufis K; Makris T; Manolis AJ; Tousoulis D
    Pharmacol Res; 2019 Aug; 146():104279. PubMed ID: 31108185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-blocker target dosing and tolerability in a dedicated heart failure clinic in Johannesburg.
    Bolon J; McCutcheon K; Klug E; Smith D; Manga P
    Cardiovasc J Afr; 2019 Mar/Apr 23; 30(2):103-107. PubMed ID: 30740613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart Rate Control during Experimental Sepsis in Mice: Comparison of Ivabradine and β-Blockers.
    Bedet A; Voiriot G; Ternacle J; Marcos E; Adnot S; Derumeaux G; Mekontso Dessap A
    Anesthesiology; 2020 Feb; 132(2):321-329. PubMed ID: 31939847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ivabradine-Induced Torsade de Pointes in Patients with Heart Failure Reduced Ejection Fraction.
    Jang JH; Kwon SW; Lee MJ; Ko KY; Park JH; Yoon GS; Choi SH; Beak YS; Park SD; Shin SH; Woo SI; Kim DH; Kwan J
    Int Heart J; 2020 Sep; 61(5):1044-1048. PubMed ID: 32921663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.
    Fox K; Komajda M; Ford I; Robertson M; Böhm M; Borer JS; Steg PG; Tavazzi L; Tendera M; Ferrari R; Swedberg K
    Eur Heart J; 2013 Aug; 34(29):2263-70. PubMed ID: 23536611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
    Das D; Savarese G; Dahlström U; Fu M; Howlett J; Ezekowitz JA; Lund LH
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28903983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.